Curis
CRIS
#10201
Rank
โ‚น1.56 B
Marketcap
โ‚น121.28
Share price
0.00%
Change (1 day)
-63.74%
Change (1 year)

EPS for Curis (CRIS)

EPS in 2025 (TTM): -โ‚น315.89

According to Curis's latest financial reports the company's current EPS (TTM) is -โ‚น329.70. In 2024 the company made an earnings per share (EPS) of -โ‚น631.55 an increase over its 2023 EPS that were of -โ‚น810.32.

EPS history for Curis from 2011 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-โ‚น315.89-49.98%
2024-โ‚น631.55-22.06%
2023-โ‚น810.32-26.25%
2022-โ‚น1,09922.3%
2021-โ‚น898.36-25.37%
2020-โ‚น1,204-30.93%
2019-โ‚น1,743-2.02%
2018-โ‚น1,779
2016-โ‚น4,043-10%
2015-โ‚น4,492138.1%
2014-โ‚น1,88740%
2013-โ‚น1,348-25%
2012-โ‚น1,79766.67%
2011-โ‚น1,078

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Exelixis
EXEL
โ‚น213.81-164.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
โ‚น126.67-138.42%๐Ÿ‡บ๐Ÿ‡ธ USA
Spectrum Pharmaceuticals
SPPI
-โ‚น32.34-90.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-โ‚น303.65-7.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
โ‚น154.52-146.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚น266.81-180.93%๐Ÿ‡บ๐Ÿ‡ธ USA
Cel-Sci
CVM
-โ‚น1,010 206.27%๐Ÿ‡บ๐Ÿ‡ธ USA